Leititis J U
Universitätskinderklinik Freiburg.
Klin Padiatr. 1991 Nov-Dec;203(6):420-3. doi: 10.1055/s-2007-1025466.
Thrombolytic treatment with urokinase (5000 U/ml) or streptokinase can restore patency in central venous catheters occluded by thrombosis. In pediatric patients preferable urokinase should be used. The therapy in case of catheter-induced central venous thrombosis is a continuous urokinase infusion (125,000 U/1.73(2)/h) for about 3 to 8 days, followed by a long-term heparinization. The treatment in persistent withdrawal occlusion is significantly shorter, a few hours of systemic lysis are sufficient. The treatment of choice in case of chemical obstructions in patients with long-term parenteral nutrition is the injection of 0.1 N HCl in combination with Heparin. By these procedures most of obstructed central venous catheters can be reopened and maintained in place. This preserves the count of possible catheter implantation sites.
用尿激酶(5000 U/ml)或链激酶进行溶栓治疗可恢复因血栓形成而堵塞的中心静脉导管的通畅。对于儿科患者,应首选尿激酶。导管所致中心静脉血栓形成的治疗方法是持续输注尿激酶(125,000 U/1.73(2)/h)约3至8天,随后进行长期肝素化治疗。持续性拔除堵塞的治疗时间明显较短,数小时的全身溶栓就足够了。对于长期肠外营养患者化学性梗阻的情况,治疗选择是注射0.1 N盐酸并联合肝素。通过这些操作,大多数堵塞的中心静脉导管可重新开通并保留在位。这保留了可能的导管植入部位数量。